NCT04264026View on ClinicalTrials.gov

MDMA-Assisted Psychotherapy in Veterans With Combat-Related, Refractory PTSD

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

July 29, 2021

Primary Completion Date

May 1, 2025

Study Completion Date

May 1, 2025

Conditions
Post Traumatic Stress DisorderCombat Stress Disorders
Interventions
DRUG

3,4-methylenedioxymethamphetamine

Bottles are labeled with a unique container number, protocol number, IMP name, lot number, sponsor name and a statement that the IMP is restricted to clinical trial use only.

Trial Locations (1)

92357

VA Loma Linda Health Care System, Loma Linda

All Listed Sponsors
collaborator

Multidisciplinary Association for Psychedelic Studies

OTHER

lead

VA Loma Linda Health Care System

FED

NCT04264026 - MDMA-Assisted Psychotherapy in Veterans With Combat-Related, Refractory PTSD | Biotech Hunter | Biotech Hunter